Back to top

Gentex (NASDAQ:GNTX): A Decent Value Opportunity with Strong Fundamentals

GENTEX CORP (NASDAQ:GNTX) was identified by a Decent Value screen, a strategy that targets stocks offering strong valuation scores while still maintaining decent profitability, financial health, and growth. This approach aligns well with the principles of value investing, where the goal is to buy companies that appear undervalued relative to their intrinsic worth without sacrificing quality. Gentex's fundamental rating of 7 out of 10 reflects a solid mix of these attributes, making it a candidate worth examining for value-focused investors.

GENTEX CORP stock chart

Valuation: A Key Pillar of the Strategy

At the heart of any value investment is a compelling valuation. Gentex trades at a Price/Earnings ratio of 12.11, which is well below the S&P 500 average of 25.88 and also cheaper than roughly 81% of its peers in the Automobile Components industry. The Price/Forward Earnings ratio of 10.58 further underscores this discount. Moreover, the low PEG ratio suggests that the market is not yet pricing in the expected earnings acceleration, adding to the stock's appeal. Investors who want to dive deeper into these metrics can review the complete breakdown on the fundamental analysis page.

Financial Health and Profitability

A cheap stock is only a good value if the underlying business is sound. Gentex scores an 8 out of 10 on both health and profitability, two areas that value investors must check to avoid value traps. Key indicators include:

  • Altman Z-Score: 8.62, signaling very low bankruptcy risk and outperforming 93% of industry peers.
  • Debt/Equity: 0.00, virtually no leverage, with a Debt to Free Cash Flow ratio of 0.01 years.
  • Liquidity: Current ratio of 2.72 and quick ratio of 1.54, both well above safety thresholds.
  • Profitability: Return on Invested Capital of 16.64% (top 5% of industry), operating margin of 19.11%, and a profit margin of 14.53%.

These figures indicate a company that generates strong returns on capital, operates with minimal debt, and enjoys ample liquidity — all traits that reduce the risk of permanent capital loss and support long-term value creation.

Growth: Modest but Accelerating

While growth is not the primary driver for value investors, decent growth helps ensure that the undervaluation is not due to a deteriorating business. Gentex's growth rating of 5 is middle-of-the-road but shows encouraging signs:

  • Past EPS growth: 7.03% (last year), 4.68% average over recent years.
  • Revenue growth: 9.55% last year, 8.46% average.
  • Future EPS growth is expected to accelerate to 14.75% annually, while revenue growth moderates to 5.60%.

The acceleration in EPS growth, combined with an already low valuation, creates a scenario where earnings could catch up to the stock price, potentially unlocking further upside.

Why This Combination Matters for Value Investors

Value investing is not just about buying the cheapest stocks; it is about buying quality at a discount. Gentex demonstrates that it is possible to find a company with near-zero debt, high profitability, and a solid dividend yield of 2.00%, all while trading at a P/E ratio in the low teens. The margin of safety is supported by the strong financial health rating and the reasonable growth outlook. However, investors should remain aware of risks such as margin compression (operating and profit margins have declined recently) and slower revenue growth ahead. Still, for those seeking value opportunities with a quality bias, Gentex presents a balanced proposition.

Investors interested in exploring more stocks that match this Decent Value methodology can use this screener link to identify additional candidates.

Disclaimer: This article is for informational and educational purposes only and does not constitute financial advice or a recommendation to buy or sell any security. Always conduct your own research and consider your risk tolerance before making investment decisions.

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Gentex Corporation (GNTX)